Background There has been a rapid decline in the number of young heterosexuals
diagnosed with genital warts at outpatient sexual health services since the national human …

Assess Ontario's school-based human papillomavirus (HPV) vaccination program on
reducing rates of cervical dysplasia, colposcopy services and treatment for genital warts …

Objective. Human papillomavirus (HPV) causes almost all cervical cancer in women and
contributes to vaginal, anal, oropharyngeal, and penile cancer morbidity and mortality …

Abstract Study Objective The purpose of the study was to compare human papillomavirus
(HPV) vaccination rates before and after Affordable Care Act (ACA) implementation among …

Background United States guidelines recommend human papillomavirus (HPV) vaccination
for males and females up to 26, with more recent extended coverage for those 27 to 45 …

Background We tested the hypothesis that states with higher rates of cancers associated
with human papillomavirus (HPV) would have lower HPV vaccine coverage. Methods We …

Materials and Methods: The 2016 NIS-Teen data, an annual survey conducted by the CDC
to monitor vaccination uptake in the United States is used for this study. Multivariable logistic …

It has been more than 10 years since the licensure of prophylactic human papillomavirus
(HPV) vaccines, which have been demonstrated to prevent nearly 100% of infections by …

Background Low human papillomavirus (HPV) vaccination rates early after introduction,
particularly among low income and minority adolescents, may have resulted in disparities in …

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide
and ano-genital warts (AGWs) are highly infectious. This virus is transmitted through sexual …